Learn more about our clinical services, which includes expert outpatient care and advanced diagnostic testing for all types of rheumatologic conditions.
The Massachusetts General Hospital IgG4-Related Systemic Disease Program is a national leader in the areas of clinical care and research for this recently recognized condition.
The Massachusetts General Hospital Lupus Program conducts groundbreaking research and takes a multidisciplinary approach to caring for patients with systemic lupus erythematosus (lupus).
The Massachusetts General Hospital Lyme Disease Program is recognized internationally for its expertise in researching, diagnosing and treating the manifestations of Lyme disease, including Lyme arthritis.
The Massachusetts General Hospital Rheumatoid Arthritis Program is recognized internationally for its innovative research into this condition and state-of-the-art diagnostic and treatment services.
The Massachusetts General Hospital Rheumatology Musculoskeletal (MSK) Ultrasound Program offers diagnosis and treatment for musculoskeletal pain and disorders such as arthritis and gout.
The Massachusetts General Hospital Scleroderma Program provides expert multidisciplinary care for scleroderma (systemic sclerosis) and conducts research to enhance our understanding of the disease and develop new treatments.
The Massachusetts General Hospital Sjögren's Syndrome Program is conducting promising research while also evaluating, treating and educating patients with Sjögren's syndrome.
Rheumatologists at the Massachusetts General Hospital Vasculitis Program have extensive experience recognizing how vasculitis can affect different organs and take a team approach to safely and effectively treating all forms of the disease.
There are no results found in this category.
Use the search box in the upper right corner of the page to find related content.